Overview

Drug Interaction Study With Rosuvastatin

Status:
Completed

Trial end date:
2014-05-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to evaluate the effect of concomitant administration of BMS-986020 on the single dose Pharmacokinetics (PK) of Rosuvastatin in healthy subjects.

Phase:

Phase 1

Details

Lead Sponsor:

Bristol-Myers Squibb

Treatments:

Rosuvastatin Calcium